LLY

779.86

-1.89%↓

JNJ

152.52

+0.03%↑

ABBV

185.27

-0.73%↓

NVO

68.23

+1.32%↑

UNH

307.35

+1.39%↑

LLY

779.86

-1.89%↓

JNJ

152.52

+0.03%↑

ABBV

185.27

-0.73%↓

NVO

68.23

+1.32%↑

UNH

307.35

+1.39%↑

LLY

779.86

-1.89%↓

JNJ

152.52

+0.03%↑

ABBV

185.27

-0.73%↓

NVO

68.23

+1.32%↑

UNH

307.35

+1.39%↑

LLY

779.86

-1.89%↓

JNJ

152.52

+0.03%↑

ABBV

185.27

-0.73%↓

NVO

68.23

+1.32%↑

UNH

307.35

+1.39%↑

LLY

779.86

-1.89%↓

JNJ

152.52

+0.03%↑

ABBV

185.27

-0.73%↓

NVO

68.23

+1.32%↑

UNH

307.35

+1.39%↑

Search

Hologic Inc

Deschisă

SectorSănătate

64.98 0.31

Rezumat

Modificarea prețului

24h

Curent

Minim

64.42

Maxim

66.15

Indicatori cheie

By Trading Economics

Venit

-218M

-17M

Vânzări

-17M

1B

P/E

Medie Sector

27.071

50.291

EPS

1.03

Marjă de profit

-1.731

Angajați

7,063

EBITDA

-359M

-7M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+3.39% upside

Dividende

By Dow Jones

Următoarele câștiguri

28 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-521M

14B

Deschiderea anterioară

64.67

Închiderea anterioară

64.98

Sentimentul știrilor

By Acuity

27%

73%

71 / 380 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Hologic Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 mai 2025, 18:46 UTC

Principalele dinamici ale pieței
Achiziții, Fuziuni, Preluări

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

27 mai 2025, 20:07 UTC

Achiziții, Fuziuni, Preluări

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 mai 2025, 19:06 UTC

Achiziții, Fuziuni, Preluări

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 mai 2025, 18:26 UTC

Achiziții, Fuziuni, Preluări

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Comparație

Modificare preț

Hologic Inc Așteptări

Obiectiv de preț

By TipRanks

3.39% sus

Prognoză pe 12 luni

Medie 66.45 USD  3.39%

Maxim 71 USD

Minim 60 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHologic Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

14 ratings

5

Cumpărare

9

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

52.69 / 58.605Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Weak Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

71 / 380 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.